Catamount Wealth Management »

Allogene Therapeutics shares owned by Catamount Wealth Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Catamount Wealth Management from 13F filings

Historical chart of Catamount Wealth Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Catamount Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Catamount Wealth Management

Quarter filed Position value Share count Share price at filing
2019-03-31 $7.0k 230 30.43
2018-12-31 $7.0k 230 30.43